Adolescent Mood During Puberty and Testosterone
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Oct 2, 2023
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how puberty and hormone changes affect mood in adolescents, particularly focusing on differences between boys and girls. Researchers are looking at why girls are more likely to experience depression during this time, while boys are more prone to issues like ADHD. They want to understand the brain and hormonal changes that might contribute to these differences, especially after stressful life events or if a young person is feeling moderately depressed.
To participate in this study, adolescents aged 11 to 14 are eligible if they have experienced a stressful event in the past year or have a moderate level of depression. They should have their own mobile device to use specific apps that help track their mood and experiences. Participants will not be able to join if they have previously taken part in the Healthy Minds Program, have regular meditation practices, or are currently on certain medications or hormones. Those who join can expect to contribute valuable information to help improve understanding of adolescent mental health during puberty.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 11 and 14
- • Have their own personal mobile device and capability to download the MyCap and Healthy Minds apps
- • Experienced a stressful life event within the last year, or endorse moderate depression (defined by a CES-DC score 16 or higher)
- Exclusion Criteria:
- • Previous experience with the Healthy Minds Program
- • Regular meditation practice
- • Current or history of manic episodes, psychotic symptoms, or current suicidal intent
- • Taking any form of exogenous hormones or intrauterine device (IUD) within one month of participation in the study
- • Taking medications that directly alter cardiovascular or neurological function
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Elizabeth Andersen, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported